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Background: The impact of air pollution on the respiratory system has been estimated on the basis of respiratory
symptoms and lung function. However; few studies have compared lung inflammation in healthy and asthmatics
children exposed to high levels of air pollution. The aim of the study was to elucidate the modulatory effect of air
pollution on Cysteinyl-leukotrienes (Cys-LTs) levels in exhaled breath condensate (EBC) among healthy and
asthmatic children.
Methods: We performed a cross-sectional comparative study. Children between 7–12 years of age, asthmatics and
non-asthmatics, residents of a city with high levels of PM10 were included. In all cases, forced spirometry, Cys-LTs
levels in EBC, and the International Study of Asthma and Allergies in Childhood questionnaire were evaluated. We
also obtained average of PM10, CO, SO2 and O3 levels during the period of the study by the State Institute of
Ecology.
Results: We studied 103 children (51 asthmatics and 52 non-asthmatics). Cys-LTs levels were higher in asthmatics
than in non-asthmatics (77.3 ± 21.6 versus 60.3 ± 26.8 pg/ml; p = 0.0005). Also, Cys-LTs levels in children with
intermittent asthma were lower than in children with persistent asthma (60.4 ± 20.4 versus 84.7 ± 19.2 pg/ml;
p = 0.0001). In the multiple regression model, factors associated with levels of Cys-LTs were passive smoking
(β = 13.1, p 0.04) and to be asthmatic (β = 11.5, p 0.03).
Conclusions: Cys-LTs levels are higher in asthmatic children than in healthy children in a contaminated city and its
levels are also associated with passive smoking.
Keywords: Air pollution, Lung inflammation, Cysteinyl-leukotrienes, Exhaled breath condensateBackground
Air pollution has become a global public health prob-
lem. It is considered by the World Health Organization
(WHO) as a global health priority, according to a recent
study, the air pollution is responsible for 1.4% of all
deaths in the world [1].
Epidemiological studies show that exposure to air pol-
lution, is associated with an increased incidence and se-
verity of asthma [2,3], acute respiratory infections [4,5],* Correspondence: blinares70@yahoo.com.mx
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article, unless otherwise stated.pulmonary function decline [6] and other chronic ob-
structive pulmonary disease [7,8].
Most of literature has taken as health indicators, hos-
pital admissions or attendance at the emergency services.
However, not all people are exposed to this impact on
health in the same conditions; the most vulnerable groups
are children and elderly people. The child population has
certain characteristics that make them more susceptible to
environmental impact unlike adults. Thus, from the point
of view of the dose compared with adults, children
breathe faster and play outdoors often, therefore, due to
its lower weight is greater exposure per unit mass. On the
other hand, due to its constant state of development and
growth, physiologically immune system and organs areCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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contaminants easily obstructs their airways [9].
The contaminants frequently associated with asthma ex-
acerbations are: carbon monoxide, ozone, nitrogen diox-
ide, sulfur dioxide and particulate matter with a diameter
of 10 micrometers or less (PM10). Continuous exposure to
low doses of allergens in patients sensitized causes in-
creased bronchial hyperreactivity, decreased steroid recep-
tor affinity, and therefore, increases the susceptibility to
asthma attacks and reduces the response to treatment ste-
roids [3,10].
There are two proposed mechanisms for respiratory
disease due to exposure to air pollutants. The first involves
a reduction in the forced vital capacity, through to the
stimulation of neural receptors in the upper airway due to
the release of cyclooxygenase, products of the arachidonic
acid [11]. The other mechanism has been linked to the re-
cruitment of inflammatory cells and in general to the in-
flammation process [12-14].
The impact of air pollution on the respiratory system
has been estimated in terms of respiratory symptoms, lung
function and other outcomes. However, there are few
reports worldwide about the involvement of cysteinyl-
leukotrienes (Cys-LTs) in the pathogenesis of lung inflam-
mation [15,16]. The aim of this study was to elucidate the
modulatory effect of air pollution on Cysteinyl-leukotrienes
(Cys-LTs) levels in exhaled breath condensate (EBC) among
healthy and asthmatic children.Methods
Study population
We performed a cross-sectional comparative study. As in-
flammation biomarker Cisteinyl-leukotrienes in exhaled
breath condensate (EBC) was measured. A sample size of
37 subjects per group was calculated (asthmatic and non-
asthmatic) using the statistic t, according to detect a dif-
ference of at least 10% in the levels of Cys-LTs with an
alpha of 0.05, unilateral beta 0.10 and a power of 0.90. In-
creased 20% for losses (n = 90). We included children
7–12 years of age, asthmatics and non-asthmatics, resi-
dents of a city with high levels of PM10.
The study took place in the urban area of León, Mexico
from September, 2010 to March, 2011. The municipality
has a territorial extension of 1 200 km2 (3.9% of the total
state surface), a population of 1.5 million inhabitants and
a population density of 1,250 inhabitants per km2. Its cli-
mate is temperate most of the time, and it forms part of
the industrial corridor of the state. According to reports
of the National Institute of Ecology [17], it is one of the
cities with high air pollution by PM10 (average of
64.5 μg/m3 with a range of 41.2-82.6 ug/m3). The main
producers of this pollutant are sources of area and emis-
sions from motor vehicles.We studied healthy or asthmatics children who were
able to cooperate with the test. Children who had
wheeze due to concomitant nonasthmatic chronic airway
diseases like cystic fibrosis or patients with asthma who
had suffered an exacerbation within a month of the
study period were excluded from the study. Children
with asthma were recruited from the Pediatric Outpa-
tients Clinics of Regional General Hospital of Leon,
Mexico. Normal age-matched control subjects were re-
cruited from a public elementary school located in the
same city 2 km away from the monitoring station. None
of the participants had been treated with leukotriene in-
hibitors. Permission was obtained from the authorities of
the State Department of Education and from the partici-
pating school. The parents, as well as each of the partici-
pants, were informed about the objective of the study
and the procedures before obtaining consent to partici-
pate. The study was approved by the Research Commit-
tee of the Department of Medicine and Nutrition of the
University of Guanajuato, and was authorized with the
registration number 358–10.
Study design
A detailed history was taken and physical examination
performed on each child. Weight and height were re-
corded to calculate the body mass index (BMI). Asthma
was diagnosed when the child had episodic cough, breath-
lessness, and wheeze responsive to bronchodilators with
or without steroids. The medical and sociodemographic
history were obtained through the questionnaire proposed
by the International Study of Asthma and Allergies in
Childhood (ISAAC) validated in a previous study [6].
Lung function was measured by forced spirometry. The
spirometry was performed with a spirometer EasyOne®
(NDD, Technopark darned Switerland), which meets the
diagnostic criteria for precision, accuracy and linearity,
established by the American Thoracic Society (ATS,
1994). To carry out follow the recommendations of the
ATS and the following parameters were obtained: Forced
Vital Capacity (FVC), Forced Expiratory Volume in one
second (FEV1) and FVC/FEV1 ratio. The presence of spi-
rometric values below the fifth percentile was considered
abnormal according to height, weight, gender and age.
The quality of spirometric tests was assessed by several
criteria in addition to the automatic evaluation done by
the software device. One was the number of acceptable
maneuvers according to ATS, 1 ranging from 0 to 3, the
highest kept by the spirometric software. Another indi-
cator of quality was reproducibility. FEV1 and FVC were
considered reproducible according to ATS criteria when
the best two trials differed by not more than 200 mL. A
total of 97.5% of the tests achieved reproducibility within
150 mL fulfilling the 2005 ATS-ERS criteria. Reference
values of Hankinson et al. [18] for Mexican-Americans






Gender (male/female) 30/22 27/25 0.55
Age (years) 9.5 ± 1.5 8.5 ± 0.9 0.0004
Weight (kg) 36.7 ± 6.0 31.8 ± 6.8 0.004
BMI (kg/m2) 18.9 ± 4.2 17.3 ± 2.7 0.02
FVC (liters) 2.2 ± 0.6 2.0 ± 0.3 0.06
FVC (% predicted) 97.8 ± 15.3 98.2 ± 24.1 0.91
FEV1 (liters) 1.7 ± 0.5 1.6 ± 0.2 0.30
FEV1 (% predicted) 86.0 ± 14.7 93.6 ± 10.8 0.003
FEV1/FVC% 78.3 ± 8.3 82.9 ± 9.2 0.01
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fill ATS criteria of quality after the first spirometric evalu-
ation. The presence of spirometric values below the 5th
percentile of reference values were considered abnormal.
The obstructive pattern was defined by the diminution of
the FEV1 and FEV1/FVC index, the restrictive pattern by
diminution of the FVC, with normal FEV1/FVC index,
and mixed pattern by diminution of FVC and FEV1.
Exhaled breath condensate analysis
Exhaled breath condensate collection was performed
using the RTube™ EBC collection system (Respiratory
Research, Inc, Charlottesville, Virginia, USA). Subjects
breathed tidally for 15 minutes, nose clips were not
worn, because they are somewhat uncomfortable. The
condensate samples were obtained at an average ambient
temperature of 13°C. The mean volume collected was
1.2 (range 0.7–1.1.8) ml. The collected condensate was
melted and aliquots of 100 μL stored in small plastic
tubes at −80°C.
Biochemical assays
Cys-LTs (LTC4, LTD4, and LTE4) levels were measured
with a specific enzyme immunoassay (Cayman Chemical,
Ann Arbor, MI), at a wavelength of 410 nm. The lower
limit of detection for these assays was 4 pg/ml. The
intra-and interassay coefficients of variation of the kits
were 10% or less and every sample was assayed by
duplicate.
Data analysis
All data are expressed as means ± SEM or as median and
95% CI according to their normal distribution. Comparison
of demographic and clinical data was performed using chi
square or Student’s t test according to the type of variable.
Comparison of demographic data was done by a chi-square
test. To compare the concentration of exhaled Cys consid-
ered three groups: non-asthmatics, intermittent asthma and
persistent asthma and use analysis of variance with post
hoc Tukey test. We used the Pearson correlation test to
determine the association between levels of cysteinyl-
leukotrienes and spirometric values. Stepwise multiple re-
gression was performed with cysteinyl-leukotriene levels as
the dependent variable and group, age, gender, body mass
index, the antecedent atopy, exposure to allergens and pas-
sive smoking as regressors. Air pollutants were captured as
mean values of all the period of the study.
Results
Clinical characteristics
One hundred three subjects were enrolled into the study,
with a mean age of 9.0 ± 1.3 years. We observed no signifi-
cant difference in gender distribution between groups.
Asthmatics children were older and showed higher BMIthan those non-asthmatics. In contrast, they showed lower
FEV1 and FEV1/FVC% than healthy children (Table 1).
Allergic diseases and respiratory symptoms
According to the ISAAC questionnaire, the frequency of
respiratory symptoms (cough, wheezing, and rhinorrhea)
and allergic (rhinitis and eczema) diseases was signifi-
cantly higher in asthmatic children (Table 2).
Pulmonary function
The spirometry data showed that forced vital capacity in
asthmatic children was higher than in non-asthmatics,
although this difference was not significant. No signifi-
cant differences were observed in absolute FEV1. In con-
trast, the percentage of predicted FEV1 in non-asthmatic
children was significantly higher than in asthmatics (p =
0.003). According to spirometric values, lung function
abnormalities were higher in the asthmatic group than
in non-asthmatics. Also, impaired lung function “ob-
structive-type”, was more common in asthmatics, but we
did not observe significant difference in “restrictive-type”
or “mixed-type” disorders between groups (Table 2).
Air pollutants
According to reports of the State Institute of Ecology,
average PM10 levels during the period were 196.7 μg/m
3
with a range of 64.1- 217.9 μg/m3 which represents
176 days of measurement. The corresponding averages
for other pollutants were: O3 = 26.32 μg/m
3 (15.8-30.9),
SO2 = 7.8 μg/m
3 (5.0-11.6), CO = 0.96 ppm (0.57-1.68),
and NO2 = μg/m
3 19.6 (14.6-26.8) in the same period of
time.
Exhaled Cys-LTs
The Cys-LTs levels were detected in the EBC of all children,
with mean of 68.7 ± 25.7 pg/ml. The Cys-LTs levels were
significantly higher in asthmatics than in non-asthmatics
(77.3 ± 21.6 versus 60.3 ± 26.8 pg/ml; p = 0.0005). The aver-
age concentration of exhaled Cys-LTs in children with
Table 2 Prevalence of respiratory symptoms, allergic diseases and lung function disorders
Asthmatic n = 51 Non-asthmatic n = 52 OR p value
No. (%) No. (%) (95% CI)
Respiratory symptoms:
Cough 47 (92.1) 13 (25.0) 3.6 (2.2 - 5.9) 0.0001
Wheezing 50 (98.0) 5 ( 9.6) 10.2 (4.4 - 23.4) 0.0001
Rhinorrhea 51 (100) 44 (84.6) 1.1 (1.05 - 1.3) 0.003
Allergic diseases:
Rhinitis 24 (47.0) 3 (5.7) 8.1 (2.6 - 25.4) 0.0001
Eczema 15 (29.4) 1 (1.9) 15.2 (2.1 - 111.5) 0.0001
Type of impaired lung function: 16 (31.4) 6 (11.4) 2.7 (1.1 - 6.3) 0.02
Obstructive 10 (19.6) 2 (3.8) 5.2 (1.2 - 22.5) 0.01
Restrictive 1 (1.9) 2 (3.8) 0.65 (0.06 - 6.9) 0.56
Mixed 5 (9.8) 2 (3.8) 2.9 (0.5 - 12.5) 0.22
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dren with persistent asthma (66.4 ± 20.4 versus 84.7 ±
19.2 pg/ml; p = 0.02). The analysis of variance with post
hoc Tukey test showed that Cys-LTs levels in children
with persistent asthma were significantly higher than in
those with intermittent asthma (p = 0.02) and non-
asthmatics (p = 0.001) Figure 1.
There was no correlation between Cys-LTs levels and
spirometric parameters (FVC, FEV1, FEV1/FVC%). In the














Figure 1 Cys-LTs levels in exhaled breath in healthy children and those
(84.7± 19.2 pg/ml) were significantly higher than in those with intermittent as
p=0.001).Cys-LTs were passive smoking (β = 13.1, p 0.04) and to be
asthmatic (β = 11.5, p 0.03).Discussion
It is well documented that high levels of many airborne
pollutants can adversely affect many systems of the
human body. Epidemiological studies have shown that
exposure to air pollutants, even at levels below the stand-
ard, are associated with an increased incidence andittent asthma Persistent asthma
with asthma. Cys-LTs levels in children with persistent asthma
thma (66.4 ± 20.4 pg/ml; p=0.02) and non-asthmatics (60.4 ± 20.4 pg/ml;
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as chronic obstructive pulmonary disease exacerbation.
To know the adverse effects of air pollution on human
health, time series ecological studies have been used. In
our country there are two multicenter studies conducted
in 16 cities, which analyze the effects of air pollutants on
mortality (EMECAM) and morbidity (EMECAS project).
These works show a significant association between air
pollutants and health indicators.
In this study, the prevalence of respiratory symptoms
(cough, wheezing, and rhinorrhea) and allergic diseases
(rhinitis and eczema) were significantly higher in chil-
dren with asthma than in healthy children, as well as the
prevalence of impaired lung function measured by spir-
ometry. These results are consistent with the well known
facts that asthmatic children have more respiratory
symptoms, lower lung function, and evidence of airway
inflammation compared to non-asthmatic children [4-6]
which also increase in places with high air pollution.
The Cys-LTs levels in exhaled breath condensate were
higher in children with asthma than in non-asthmatics.
These findings agree with those reported by Csoma Z
et al. [19] and by Baraldi et al. [20], in healthy and asth-
matic schoolchildren 4–16 years old. Also Cys-LTs levels
were higher in persistent than in intermittent asthma,
these results support that Cys-LTs play an important
role in the mechanism of lung inflammation. For ex-
ample it has been described that they participate in the
pathophysiology of airway remodelling [21] and in the
pathophysiology of asthma [22]. In vitro studies have
shown that LTD4 augments epidermal growth factor-
induced human airway smooth muscle proliferation [23]
and that LTC4 up regulates collagenase expression and
synthesis in human lung fibroblasts [24]. Furthermore,
animal models have shown that an increase in airway
smooth muscle cells observed in allergen-treated Brown
Norway rats was reduced by CysLT1 receptor antagon-
ism [25]. So, it seems that current asthma treatment
mainly based on disease severity classification has to
change more focused on the individual patient [26].
As a relevant observation, Cys-LTs levels in EBC were
higher in our study than in others [19,20,27]. Even
healthy children showed higher levels (60.3 pg/mL) than
those reported by Czoma et al. [19] (18.5 pg/mL) and
Baraldi et al. [20] (4.3 pg/mL). This could be related to
PM10 levels recorded in our city, because it has been re-
ported that PM10 trigger a systemic reaction from lungs
to bloodstream in mice [28], and its levels were higher
than those considered normal in the Mexican’s Official
Norm [29]. Also, in the last three years the average
levels of PM10, reported by the Air Quality in Europe in
cities of similar studies were 28 μg/m3 in London, UK
and 49.4 μg/m3 in Padova, Italy [30]; significantly lower
than in our population (196.7 μg/m3). So, it supportsadditional insight into the toxicity of PM10 and could
facilitate shedding light on mechanisms underlying the
development of urban air pollution related diseases.
Other factors that can also explain this difference are
genetics, lifestyle, socioeconomic and geographic loca-
tion. It is unlikely that the variation between Cys-LTs
levels may be due to factors related to the sample pro-
cessing, because it was collected by the same method,
and a similar kit was used.
Another factor related to Cys-LTs levels was passive
smoking. Supporting this relationship, recently the expos-
ure to environmental tobacco smoke (ETS), as assessed by
urinary cotinine levels, was associated with an increased
urinary concentration of LTE (4) [31]. Also, it has been re-
ported that ETS modifies the acute effects of low-level
ambient PM(2.5) exposure on childhood asthma. This
negative interaction, the smaller effect of particulate mat-
ter exposure in children exposed to higher ETS, may be
related to a nonlinear dose–response relationship between
asthma mediators and particulate exposures [32].
One limitation of the study is that it was a cross-
sectional study; it would be desirable to measure the levels
of Cys-LT at least once in every season to determine their
variability and association with levels of pollutants and re-
spiratory health damage. Also, in future studies, independ-
ent biomarkers of airway inflammation and/or oxidative
stress including exhaled nitric oxide [33] and EBC concen-
trations of isoprostanes [34,35] and metabolites [36,37]
should be measured for a more complete assessment of
airway inflammation in children exposed to high PM10
levels. Analysis of breath volatile organic compound
profiles with electronic noses [38] would be particularly
interesting as this technique has been shown to be re-
producible and reliable [39], as well as another new
specific non-invasive technique for assessing airway in-
flammation such as nuclear magnetic resonance-based
metabolomics of EBC [37]. Also, pharmacological stud-
ies aimed at measuring EBC CysLTs after treatment with
leukotriene receptor antagonists in asthmatic children
exposed to high PM10 levels or passive smoking are re-
quired [40].
However, strength in our study is that we performed a
re-power calculation using the difference in standard de-
viations and means in addition to only 10% difference
between groups in Cys-LT levels and the result was 93%.Conclusions
Cys-LTs levels are higher in asthmatic children than in
healthy children in a contaminated city and its levels are
also associated with passive smoking.Competing interests
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